MissionIR Articles
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Enters Distribution Agreement for Evolve(TM) in Australia and New Zealand
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced its entry into a distribution agreement with Evicom, an environmental management firm based in Australia with distribution throughout Australia, New Zealand and the surrounding region. SenesTech has developed and is commercializing a proprietary technology for managing animal pest populations, primarily…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces New Research Collaborations, Expansion of Nonclinical Programs into New Therapeutic Indications
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, is expanding its nonclinical programs into new indications. According to the announcement, the company is expanding through sponsored research agreements and material transfer agreements with several academic research collaborators. The programs will be focused on studying…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Partners with Carbonsight to Deliver Data-Driven Decarbonization, Sustainable Energy Solutions
Correlate Energy (OTCQB: CIPI), a growth-oriented distributed energy company, has entered a strategic partnership with Carbonsight (by Autocase), an online decarbonization planning tool for real estate portfolios. According to the announcement, the collaboration calls for Carbonsight to facilitate the development of building and portfolio plans focused on achieving carbon-reduction targets as well as allowing building…
-
MissionIRNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Introducing Breakthrough Technology, Potential ‘Game Changer’ for the Cannabinoid Industry
Astrotech (NASDAQ: ASTC) is an instrumentation company that is focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM). Its subsidiary, AgLAB Inc., has breakthrough mass spectrometry technology in its AgLAB-1000-D2 mass spectrometer, a ruggedized factory floor analytical instrument designed to quickly and easily analyze complex chemical compounds found in organic plant materials, and the Maximum…
-
MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Disrupting Traditional Boating Industry with Electric Power
Vision Marine Technologies Inc. (NASDAQ: VMAR) is dedicated to pioneering the clean-energy transition on the water. “Boating magazine announced its Boat of the Year category winners for 2023, and the Four Winns H2e came out on top in the Runabout category. The Four Winns bowrider is powered by Vision Marine Technologies’ E-Motion, a 180 HP…
-
MissionIRNewsBreaks – H.C. Wainwright & Co. Reiterates ‘Buy’ Rating, $6 PT on Longeveron (NASDAQ: LGVN)
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, was spotlighted in a recent H.C. Wainwright & Co. research report after the Company’s announcement about receiving a Notice of Allowance from the U.S. Patent and Trademark Office (“USPTO”) for a patent application related to the use of Lomecel-B(TM)…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Bollinger’s Receipt of IRS Approval for $40K Commercial EV Tax Credit
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors (“Bollinger”) has received IRS approval as a “qualified manufacturer” for clean vehicle credits under the Inflation Reduction Act of 2022 (the “IRA”). According to the announcement, the designation enables the Bollinger B4 chassis cab to qualify for the IRA’s new…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Eyes Successful 2024 on Momentum and Achievements with Solar Projects
Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is capitalizing on the continued corporate push for financially positive decentralized energy generation. “CIPI recently announced the successful commissioning of a major solar project located in American Tire Distributors’ (‘ATD’) Huntersville, North Carolina-based headquarters. This follows the successful…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation at This Month’s BIO CEO & Investor Conference
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will be represented at the upcoming BIO CEO & Investor Conference. The conference is scheduled for Feb. 26–27, 2024, in New York City. According to the company, CFO Ryan Confer will present at the two-day event. His…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Discusses MS Trial Results During Latest Proactive Interview
Clene (NASDAQ: CLNN) CEO Rob Etherington was the featured guest on a recent Proactive interview. According to an announcement, Etherington joined Proactive host Steve Darling to discuss recent news the company has released regarding results from its long-term, open-label extension (“LTE”) of the VISIONARY-MS trial. Clene is a late clinical-stage biopharmaceutical company focused on improving…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Production and Deliveries, Moves Forward with Production Line Installation
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting “great strides” with the production and deliveries of its Class 1 and Class 3 commercial EVs. In addition, the company is reporting that its subsidiary, Mullen Advanced Energy LLC, “), is moving forward with the installation of its battery-pack production line at its…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study Enrolls, Doses First Patient
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study of Reqorsa(R) therapy (quaratusugene ozeplasmid). The study combines Genprex’s proprietary lead product candidate with AstraZeneca’s Tagrisso(R) to treat patients with late-stage…
-
MissionIRNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Upcoming Launch and Expansion of OPKO Health-Branded Storefront
NextPlat (NASDAQ: NXPL, NXPLW), a global e-Commerce provider, is preparing for the launch of its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited’s (“Alibaba”)(NYSE: BABA) Tmall Global in China. The move follows the company’s receipt of the initial set of approvals required to operate the store in the country. “We are pleased to reach…
-
MissionIRNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) CNM-Au8 Produces ‘Significant and Very Promising Effect’ in Parkinson’s, MS Patients
Clene’s (NASDAQ: CLNN) lead drug candidate CNM-Au8 was the subject of two Phase 2a clinical trials, REPAIR-PD and REPAIR-MS, which evaluated the effects of CNM-Au8 on brain energy metabolite levels in participants with diagnoses of idiopathic Parkinson’s Disease (“PD”) and relapsing Multiple Sclerosis (“MS”), respectively. The REPAIR-PD and REPAIR-MS Phase 2 trials expanded the documented…
-
MissionIRNewsBreaks – Turbo Energy S.A.’s (NASDAQ: TURB) Products Contributing to Sustainable Reduction of Energy Costs for Thousands of Homes and Businesses
Turbo Energy (NASDAQ: TURB) is a designer, developer and manufacturer of photovoltaic energy generation, management and storage equipment. The company recently announced it had begun marketing its revolutionary “GoSolar” household solar energy system in partnership with Solar360, the energy division of Movistar – Latin America’s largest telecommunication company and one of the world’s 500 most…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Poised with First-Mover Advantage in Class 1 and Class 3 Commercial Vehicles
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it continues to capitalize on its first-mover advantage in the U.S. market with production and deliveries of its Class 1 EV cargo vans and Class 3 EV trucks. Mullen began Class 3 vehicle production in August 2023 and Class 1 production in…
-
MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Pioneering Green-Energy Transformation on the Water
Vision Marine Technologies Inc. (NASDAQ: VMAR) is a global leader and innovator within the electric recreational boating industry. The company is pioneering clean-energy transition on the water, selling 100% electric boats, outboard motors and technology in the marine industry. “Vision Marine Technologies is certainly part of this tide of green-energy transformation. In the last several…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Expands Sales Dominican Republic, Caribbean Markets with Grupo Cavel Order
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a vehicle order from Grupo Cavel for the sale of EVs its Electric Motors dealerships located in the Dominican Republic and Caribbean. The order was for 20 CAMPUS EV cargo vans. According to the announcement, Grupo Cavel plans to order additional vehicles and…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Submission of IND for Planned Phase 1b Hypertension Trial
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”). The application covers HYPER-H23-1, the company’s upcoming planned U.S. phase 1b hypertension clinical trial of DehydraTECH-CBD. According to the announcement, the company had a successful pre-IND meeting…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced the pricing of its public offering. According to the announcement, the “reasonable best efforts” public offering involves participation from healthcare-focused institutional investors and certain officers and directors of…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Advances The Dream Bowl With Tokenized Autographs, National ESPN+ Broadcast
- MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Eyes Increased Adoption of Solutions Across Core Markets
- MissionIRNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Leveraging District-Scale Upside in Alaska’s Ambler Mining District
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Appoints Kasowitz LLP to Strengthen Intellectual Property and Litigation Capabilities
- GlobalTech Corp. (GLTK) Closes Acquisition of Moda in Pelle and Is Redefining Intelligent Retail with AI